0      0

Annex 1 Overview - What is New?

‐ May 9, 2023 4:45pm

What Is New in Annex 1? | In this presentation, a selection of Annex 1 requirements with impact on facility and equipment engineering is discussed. Although several expectations were already embedded in cGMP for the last decade, a few letters (“PUPSIT”), words (“appropriate technologies (e.g. RABS, isolators…)”) or small sentences (“For aseptic processes, direct and indirect product contact parts should be sterilized”) have a major impact on design, qualification of facilities, utilities, equipment and operations. Even tough Annex 1 allows for justifications, risk assessments and “preferable” options, the expectations for the next decade are clearly spelled out. The key challenge for the pharmaceutical industry is the development of a risk based road map and strategy to implement design and operational improvements in close collaboration with engineering partners and equipment suppliers.


You must be logged in and own this session in order to post comments.